Objective This study assessed the diagnostic rate of pulmonary tuberculosis (PTB) using fiberoptic bronchoscopy (FBS) in patients with suspected PTB, and negative pre-bronchoscopy smear and polymerase-chain reaction (PCR) in sputum.
by this infectious disease. Many PTB cases were diagnosed and reported based only on clinical findings and/or chest radiographic findings without detection of acid-fast bacilli (AFB) in smears of sputum or gastric aspirate, although some cases later show AFB-positive culture results.
Several powerful laboratory-based diagnostic examinations, such as the polymerase-chain reaction (PCR) (2) and the second generation QuantiFeron-TB (QFT2G) (3) , have recently been introduced. However, the former is a tool for rapid diagnosis, and QFT2G, a technique which has proved highly accurate in the detection of a M. tuberculosis infection, is influenced by several clinical conditions, such as immunosuppressive diseases, aging, and past infection of tuberculosis, and the presence of active tuberculosis cannot be diagnosed or excluded by the QFT2G result (4) .
The procedure of fiberoptic bronchoscopy (FBS) is generally thought to be of importance in diagnosing pulmonary diseases (5) . Since FBS has proved to be highly accurate in detecting Mycobacterium tuberculosis, the gold standard for the diagnosis of tuberculosis, FBS has been widely used to diagnose PTB in sputum smear-negative cases (6) (7) (8) (9) (10) (11) . FBS is also useful for the differential diagnosis and for the treatment of tuberculosis via the drug susceptibility test if M. tuberculosis can be obtained. However, the number of cases of smear, culture, PCR, and transbronchial biopsy (TBB) findings using FBS in previous Japanese reports is relatively small (6) (7) (8) (12) (13) (14) . Furthermore, the usefulness of FBS in patients whose pre-bronchoscopy samples showed both AFB-smear and M. tuberculosis-PCR negative results has been uncertain.
Under the current Japanese law, hospitalization is recommended for patients with suspected infectious tuberculosis based on clinical judgment alone; a positive sputum smear result for AFB is not necessarily required. Therefore, it is very important to differentiate other diseases and obtain a rapid diagnosis of PTB in patients with suspected PTB in order to ensure their prompt hospitalization for treatment. Here, we assessed the diagnostic accuracy of FBS in patients with culture-positive PTB whose sputum smears for AFB and sputum PCR for M. tuberculosis were both negative when performing FBS.
Materials and Methods
When reviewing the usefulness of a procedure for diagnosing certain diseases in suspected cases, objectives must be clearly defined in advance, and the value of the test is usually evaluated by calculating the sensitivity, specificity, and positive predictive value, etc. This can be done by recording the number of true-positive findings, false-positive findings, true-negative findings, and false-negative findings in a 2×2 table, and then comparing the various incidences. However, if AFB is not detected in sputum samples, then PTB is often clinically diagnosed by chest radiographic findings, the presence of the epithelioid cell granuloma in a TBB, and more recently, by the positive results of the QFT2 G examination alone, followed by empirical anti-PTB treatment while waiting for culture results. Furthermore, since cases of pulmonary non-tuberculous mycobacteriosis are included among the suspected cases of PTB, positive findings of epithelioid cell granuloma and sputum smear-positive for AFB could also be indicative of this non-tuberculous condition, thus making it difficult to develop an accurate protocol in a prospective study based on the 2×2 table as described  above. Therefore, in many studies investigating the usefulness of FBS for PTB diagnosis, objectives have been defined based on a final diagnosis of PTB (6-8, 10, 12-15) . As in those studies, the current study focused on the ability of FBS to make a diagnosis of PTB in cases that were ultimately proven to be M. tuberculosis-culture positive.
A total of 4,769 culture-positive tuberculosis patients were admitted to this hospital in the 13 year period from 1996 to 2008. The medical records of 201 PTB patients who met the following criteria for inclusion in this study were retrospectively reviewed: 1) smear-negative for AFB on admission (one to three times in sputum, and zero to twice in gastric aspirate), 2) PCR-negative for M. tuberculosis on admission (once in sputum and zero to once in gastric aspirate), 3) FBS for making a diagnosis was performed before treatment for PTB, and 4) final diagnosis of PTB was based on the identification of M. tuberculosis cultured from at least one of the following samples: sputum and/or gastric aspirates on admission (pre-bronchoscopy samples), bronchial washing and/or aspirate (bronchoscopy samples), and postbronchoscopy sputum samples. Since previous reports (6, 7) have shown post-bronchoscopy sputum examinations to be a reliable method for detecting M. tuberculosis, the examination of post-bronchoscopy sputum has now become a routine procedure, and in this study post-bronchoscopy sputum smear and culture data were automatically included if prebronchoscopy and bronchoscopy samples showed negative data. Cases with miliary tuberculosis and/or endobronchial tuberculosis were excluded, even if FBS was performed for the diagnosis of tuberculosis.
All FBS investigations performed by experienced physicians were done via the transoral or transnasal route under local anesthesia and sedation, and according to standard procedures: 1) complete inspection of the tracheobronchial trees including subsegmental bronchi and collection of a bronchial aspirate (BA) if bronchial secretions existed; 2) sampling of bronchial brushings (BB, once to three times) from the bronchial segments at which the lesion had been radiographically located; 3) TBB from the same segments; and 4) collection of a bronchial washing (BW) at the orifices of the same segment.
The evidence of a bronchoscopy positive sample was defined as follows: i) a positive sample from at least one among BA, BB, BW, and a mixture of BA and BW in smear examination for AFB; ii) a positive sample which is either among BA or BW, and a mixture of BA and BW in a PCR examination for M. tuberculosis; iii) the presence of T a b l e 1 . B a s e l i n e De mo g r a p h i c s a n d Ra d i o g r a p h i c f i n d i n g s epithelioid cell granuloma or AFB in TBB tissue; iv) a positive sample from at least one among BA, BW, and a mixture of BA and BW in culture examination for M. tuberculosis. When spontaneous sputum was not obtained, sputum was induced by either inhalation of a hypertonic, or normal saline, or a bronchodilator plus normal saline. However, the medical files showed that no distinction was made in clinical practice between spontaneous and induced sputum, and therefore these samples were grouped together into the category of pre-bronchoscopy sputum samples. Postbronchoscopy sputum examination was performed once, after the FBS procedure in all 201 cases, either on the same day as the FBS or on the following day. This study analyzed the rates of positive smear for AFB, PCR of M. tuberculosis, presence of epithelioid cell granuloma or AFB in TBB, culture of M. tuberculosis in bronchoscopy samples, culture of M. tuberculosis in prebronchoscopy samples, and smear for AFB and culture of M. tuberculosis in post-bronchoscopy samples. We also examined the drug susceptibility of M. tuberculosis identified by culture.
The findings were analyzed according to the classification of pulmonary tuberculosis designated by the Japanese Society for Tuberculosis (Gakkai Classification (16) ) in order to consider how the radiographic findings influenced the diagnostic ability of FBS. The Gakkai classification consists of 3 Types and 3 Spreads on plain chest X-rays; Type I: extensively cavitary, Type II: non-extensively cavitary, Type III: non-cavitary, Spread 1: minimal disease, Spread 2: intermediate disease, Spread 3: extensive disease.
Drug susceptibility tests before November 2001 were performed by the absolute concentration method using 1% Ogawa medium; the standard proportional method using WELLPACK was adopted in December 2001. Beginning in February 2003, the cultured M. tuberculosis was subjected to the standard method only when the obtained M. tuberculosis showed resistance to at least one of the following: isoniazid (INH), rifampicin (RFP), streptomycin sulfate (SM), and ethambutol (EB), by using the Mycobacteria Growth Indicator Tube method (BACTEC MGIT 960). This change was introduced because of reports of discrepancies in the results of drug susceptibility of M. tuberculosis between the standard and the MGIT methods (17) , and because several reports had indicated that BACTEC MGIT 960 showed a higher proportion of INH resistance than the standard method (18) .
The χ 2 test or Fisher's exact test (if adequate) were used for the statistical analysis of the frequency of various factors, and differences were considered to be significant at the p<0.05 level.
Results
The baseline demographics and radiographic findings of the 201 patients (136 males, 65 females) are shown in Table 1. The majority of patients (102/201, 51%) were aged 39 or under; only 28 patients (14%) were 70 years or older despite the fact that this age group represents over 50% of tuberculosis patients in Japan. According to the radiographic findings, as based on the Gakkai classification, Type III (non-cavitary, 156 cases) and Spread 1 (minimal disease, 119 cases) accounted for the majority of cases, both of which are thought to be less frequently associated with a positive sputum smear result than the other categories of Table 3 shows the relationship between the original baseline radiographic features and the positive rates detected with the various procedures. These results indicated that, with TBB, there was a tendency for a higher positive rate with cavitary (Type II) cases in comparison to non-cavitary (Type III) cases, although this did not reach statistical significance. However, intermediate disease (Spread 2) cases showed a significantly higher positive rate in smear (p< 0.001) and in PCR (p<0.005) examinations of the bronchoscopy samples in comparison to minimal disease (Spread 1) cases, although there were no significant differences in the positive rates between Spread 1 and 2 based on culture or TBB of bronchoscopy samples. There was no correlation between baseline demographics and radiographic findings or with the positive rates of the various diagnostics procedures.
T a b l e 3 . Re l a t i o n s h i p b e t we e n t h e P r o c e d u r e s a n d Ra d i o g r a p h i c F i n d i n g s o f P u l mo n a r y T u b e r c u l o s i s
As shown in Table 4 , the step-wise combination of results from the various examinations increases the detection rate of positive cases from 44%, based on a smear in bronchoscopy sample alone, to 92% (152/166 cases) when the results of all bronchoscopy samples and post-bronchoscopy sputum samples were combined. This should translate into the Finally, the drug susceptibility of the cultured M. tuberculosis (Table 5 ) was reviewed. The majority of cases (180/ 201, 90%) were susceptible to all four major antituberculous drugs, but the remaining 21 cases (10%) showed resistance to at least one of the anti-tuberculous drugs, for example, 13 cases were resistant to SM (10 μg/mL), 6 
T a b l e 4 . Ra p i d Di a g n o s t i c Ab i l i t y f o r P u l mo n a r y T u b e r c u l o s i s a c c o r d i n g t o t h e Cu mu l a t i v e Co mb i n a t i o n o f Da t a f r o m t h e Va r i o u s B r o n c h o s c o p i c E x a mi n a t i o n s

T a b l e 5 . Dr u g S u s c e p t i b i l i t y Re s u l t s o f Cu l t u r e -i d e n t i f i e d M. t u b e r c u l o s i s
to INH (0.2 μg/mL), 4 to RFP (40 μg/mL), and 1 to EB (2.5 μg/mL), either alone or in combination with other drugs. No significant differences were observed in drug susceptibility between the bronchoscopy-proven PTB patients and the remaining PTB patients.
This hospital is one of the selected hospitals for tuberculosis treatment. This FBS laboratory has been operating under depressurized ventilation conditions with high-efficiency filters since 1999; and all staff performing FBS procedures are required to wear an N95 mask. There have been no cases of tuberculosis, including latent tuberculosis, in the medical staff involved with FBS examinations. Seven out of
F i g u r e 1 . De f i n i t i v e d i a g n o s t i c a b i l i t y o f b r o n c h o s c o p y f o r p u l mo n a r y t u b e r c u l o s i s . Re l a t i o n s h i p b e t we e n t h e s a mp l e s a n d M. t u b e r c u l o s i s c u l t u r e -p o s i t i v e c a s e s .
the 201 (3.5%) patients had pneumothorax, with 4 out of the 7 requiring tube drainage for this complication. However, no cases required treatment except for the use of intravenous styptic measures to cope with endobronchial hemorrhage at the time of the FBS procedure, and no other serious complications were reported. Kohno (6) reported in Japan in 1990 that, in a comparison of 91 BA and BW samples obtained via FBS, the smearpositive rates were 20.9% in BA and 23.9% in BW, and culture-positive rates were 58.2% in BA and 84.8% in BW. This report also demonstrated that TBB showed positive findings in 25 of 33 cases (75.8%), which led the authors to conclude that BW was superior to BA for the definitive diagnosis of PTB and that FBS was useful for obtaining a rapid PTB diagnosis. Subsequently, Kurashima and Takano (7) also indicated that BW was superior to BA for PTB diagnosis, and Kikuchi et al (8) , based on the analysis of 50 cases using FBS, highlighted the usefulness of this procedure in a rapid (30%) and definitive (39%) PTB diagnosis. Outside Japan, the usefulness of smear and/or culture examinations of bronchoalveolar lavage fluid (BALF) obtained by bronchoscopy in patients with suspected PTB, whose sputum smear results were negative, has been shown in a few small case studies (9-11) (n=20-40). Baughman et al (19) also indicated the superiority of smears from BAL in comparison to sputum in detecting AFB (68%, 34/50 cases vs. 13%, 6/47 cases) and in obtaining cultures positive for M. tuberculosis (92%, 46/50 cases vs. 51%, 24/47 cases).
Discussion
The use of PCR examinations for M. tuberculosis detec-tion was introduced in the 1990s for the diagnosis of tuberculosis, but the sensitivity of PCR in smear-negative samples proved to be below 50%, and therefore, the 1997 guidelines of the American Thoracic Society (ATS) proposed that PCR examination should be limited to smearpositive samples (20) . However, Wong et al (21) described that 105 out of 108 sputum smear-negative PTB cases were positive for M. tuberculosis based on PCR results from BA samples. Recently, Tueller et al (15) indicated that a PCR inspection using the FBS procedure was useful for the diagnosis of tuberculosis patients who had negative smear results in sputum samples, because PCR in BAL samples showed positive results in 93 of 120 (78%) cases that ultimately proved to be culture-positive for M. tuberculosis. Several Japanese reports using a small number of cases (n=34-82) have also indicated the usefulness of PCR for the detection of M. tuberculosis in BW (12) (13) (14) . The present study established, in a relatively large sample size, high positive rates obtained in the bronchoscopy samples in patients who were culture positive, but who were negative for both their sputum smear and PCR, and has helped to confirm the validity of using FBS for PTB diagnosis.
To date, there have been few studies discussing the relationship between radiographic characteristics of PTB and positive rates of bronchoscopy samples. Kikuchi et al (8) discussed that FBS was useful for improving PTB diagnosis in cases with minimal disease, and Takahashi et al (14) indicated that the PTB diagnostic rate by FBS was higher in infiltrative shadow cases than in nodular shadow cases. The present study, for the first time, analyzed the association between radiographic features and positive rates of PTB samples in detail. The results showed that the presence or ab-sence of cavitary shadows did not affect the positive rates of the bronchoscopy samples, while the rates of smears that were positive for AFB and PCR positive for M. tuberculosis were higher in intermediate disease cases than in minimal disease cases, although there were no significant differences between those of TBB and culture. These results suggest that there is a much stronger association between the precision of FBS sampling from the PTB lesions and obtaining a definitive diagnosis of PTB than there is between the characteristics of PTB shadows on radiographs and a diagnosis; nevertheless a rapid diagnosis was more easily and more frequently obtained from shadows with a larger spread on radiographs.
Among the benefits of FBS in PTB diagnosis, is that the combination of variously derived bronchoscopy sample data such as smear and PCR of BALF (15) , smear and PCR of BW and TBB (14) can increase the ability to obtain a rapid diagnosis. The present study demonstrated that the positive diagnostic rates increased as greater numbers of bronchoscopy samples were combined. The positive rate reached 92% when smear, PCR, and TBB of bronchoscopy samples were all combined with post-bronchoscopy sputum smear, indicating the value of the combined use of bronchoscopy samples in achieving a rapid PTB diagnosis. To arrive at a definitive diagnosis of PTB by obtaining cultures positive for M. tuberculosis, FBS has previously been considered to be significant (6) (7) (8) (9) (10) (11) , and recently Dickson et al (22) also confirmed that BALF culture is superior to culture of gastric aspirate for obtaining positive culture results. In this study, we obtained positive cultures for M. tuberculosis in 175 of the current 201 cases (87%), furthermore, 80 out of the 201 (40%) cases were cases where M. tuberculosis would not have been obtained if FBS had not been performed. There were no significant differences in the radiographic features between the 80 bronchoscopy-proven PTB cases and the remaining 121 cases in which positive cultures of M. tuberculosis would have been obtained even if FBS had not been performed. These results indicate that it is not possible to predict the culture outcome of FBS using the radiographic findings.
It is possible to ascertain precisely which drugs to select as treatment for PTB by obtaining cultures of M. tuberculo-sis and conducting a drug susceptibility test. However, this aspect has not been addressed in any of the previous reports on the FBS examination. Yoshiyama et al (23) reported that about half of the multidrug-resistant tuberculosis cases have acquired resistance and that understanding drug susceptibility of cultured M. tuberculosis is very important in measuring this phenomenon. Therefore, the implementation of the drug susceptibility test is regarded as important in the current standard treatment criteria for tuberculosis (24) . Drugresistance to INH, RFP, EB, and/or SM in this study was present in 8 out of 80 cases (10%) in which PTB was diagnosed only by FBS. The use of a drug susceptibility test on cultured M. tuberculosis obtained by FBS procedures is thought to be valuable for securing the success of PTB treatment in a way that cannot be obtained by QFT2G examination.
Problems of nosocomial infection and complications are often cited as the disadvantages of FBS procedures; no cases of tuberculosis (including latent tuberculosis) have occurred among the medical staff concerned with the FBS examinations in this laboratory. The ATS also suggests that FBS should be performed with appropriate infection control precautions with BAL and/or TBB for patients in whom a diagnosis of tuberculosis has not been established from sputum (25) . We consider that the benefits of current FBS procedures outweigh the risks and its use should therefore not be avoided due to any fears of nosocomial infection.
The findings of the present study concluded that FBS is an important procedure to obtain a diagnosis for patients with suspected PTB whose sputum smear and PCR results were both negative. This conclusion is based on the ability of FBS to arrive at a rapid and definitive diagnosis, coupled with the opportunity it provides to test for drug susceptibility. Comparisons between the relative abilities of FBS and QFT-2G in tuberculosis diagnosis, the assessment of the rapidity of diagnosis achievable by combining the data from these two modalities, and also the usefulness of transcription-reverse transcription concerted reaction (TRC) examinations (26) which have been recently introduced in place of PCR examinations to evaluate bronchoscopy samples, should therefore be the focus of future studies.
